Skip to main content
Premium Trial:

Request an Annual Quote

Gregory Critchfield

Epic Sciences has appointed Sera Prognostics President and CEO Gregory Critchfield to its board. He has more than 30 years of experience in the clinical pathology and diagnostics space and was the former president of Myriad Genetics. Prior to that, Critchfield was chief medical and science officer for Quest Diagnostics. He currently is also on the boards of Integrated Diagnostics, Nodality, and Metamark Genetics.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.